Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Hospira Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (273)
Cancellation by sponsor (53)

Date

2024 (9)
2023 (7)
2022 (9)
2021 (30)
2020 (31)
2019 (28)
2018 (1)
2017 (5)
2016 (5)
2015 (4)
2014 (7)
2013 (14)
2012 (1)
2011 (10)
2010 (2)
2009 (16)
2008 (23)
2007 (61)
2006 (8)
2005 (23)
2004 (9)
2001 (2)
2000 (2)
1998 (3)
1997 (4)
1996 (1)
1994 (4)
1992 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

326 result(s) found, displaying 71 to 80

Hospira Australia Pty Ltd - Medicine administration kit, percutaneous, non-medicated, reusable Cancelled under Section 41GL(d) of the Act

3 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Dexamethasone Phosphate 4 mg/mL Solution for Injection 8 mg/2 mL vial (314127)

11 February 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Dexamethasone Phosphate 4 mg/mL Solution for Injection 8 mg/2 mL vial.
Hospira ANZATAX (Paclitaxel) Injection 30 mg/ 5 mL vial (313841)

31 January 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira ANZATAX (Paclitaxel) Injection 30 mg/ 5 mL vial.
DBL CYTARABINE 100mg/1mL injection vial Cancelled under Section 30(1)(c) of the Act

2 November 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL CYTARABINE 500mg/5mL injection vial Cancelled under Section 30(1)(c) of the Act

2 November 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL FLUOROURACIL fluorouracil 1g/20mL injection BP vial Cancelled under Section 30(1)(c) of the Act

6 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL GENTAMICIN 80mg/2mL (as sulfate) injection BP vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL SODIUM NITROPRUSSIDE FOR INJECTION Sodium nitroprusside 50mg powder for injection BP vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 8mg/2mL (as sodium) injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL VINORELBINE 10mg/1mL (as tartrate) concentrated injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd

Pages

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.